14th Mar 2019 09:53
LONDON (Alliance News) - 4D Pharma PLC on Thursday said Chief Scientific Officer Alex Stevenson purchased 24,896 shares at a price of 91.5 pence each on Wednesday for a total of GBP22,655.
Shares in 4D Pharma were up 8.0% at 111.0p on Thursday morning.
The deal edged up Stevenson's holding in the pharmaceutical company to 6.69% or 6.3 million shares.
Meanwhile, Chief Executive Duncan Peyton bought 6,770 shares for 92p each for a total of GBP6,228 with his holding roughly the same at 3.4 million shares or 9.71% from 9.68%.
These most recent transactions take the total number of director dealings so far this week to four as, on Wednesday, the company announced that Non-Executive Chair David Norwood had bought 23,725 shares at 82.36p each for GBP19,540 and Non-Executive Director Thomas Engelen had bought 4,800 shares at 85p each for GBP4,080. Both deals took place on Tuesday.
Related Shares:
DDDD.L